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Background:  While  the health-related  beneﬁts  of  intimate  partnership  are  well  documented,  little  atten-
tion  has  been  paid  to couples  exposed  to high  levels  of  social  stigma  and  exclusion.  In this  project  we
investigated  an  important  site  of  stigma  for partnerships  by collecting  accounts  of  changing  hepatitis  C
(HCV)  status  (“sero-change”)  among  couples  that  inject  drugs.  We  explored  what  these  accounts  reveal
about the  meaning  of  HCV  for these  couples,  and  how  this  understanding  contributes  to our  collective
efforts  at prevention  and  care.
Methods:  Drawing  from  a large  dataset  of  qualitative  interviews  with  couples,  we  focussed  on  those
containing  reports  of sero-change.  By adopting  a methodology  that  positioned  partnerships  rather  than
individuals  as the  primary  unit  of  analysis,  we  addressed  the  commonplace  tendency  to either  overlook
or  discount  as  dysfunctional,  the  sexual  relationships  of people  who  inject  drugs.
Results: While  some  couples  sought  greater  biomedical  understanding  as  a  means  of coming  to  terms
with sero-change,  others  drew on  alternative  logics  or “rationalities”  that  sat  ﬁrmly  outside  conven-
tional  biomedical  discourse  (privileging  notions  of  kinship,  for example).  Regardless  of  which  explanatory
framework  they  drew  on,  participants  ultimately  prioritised  the  security  of their  relationship  over the
dangers  of viral infection.
Conclusions:  Effectively  engaging  couples  in  HCV  prevention  and  care  requires  acknowledging  and
working  with  the  competing  priorities  and  complex  realities  of  such  partnerships  beyond  simply  the
identiﬁcation  of  viral  risk.  The  “new  era”  of  direct  acting  antiviral  treatments  will  provide  ongoing  oppor-
tunities  to learn  to integrate  biomedical  information  within  more  socially  sophisticated,  relationally
aware  approaches.
© 2017  Elsevier  B.V.  All  rights  reserved.
1. Introduction
While the health-related beneﬁts of intimate partnership are
well documented (Kiecolt-Glaser and Newton, 2001; Lewis et al.,
2006), little attention has been paid to couples experiencing high
levels of social stigma and exclusion, such as those who  inject drugs
and are affected by the hepatitis C virus (HCV) (Treloar et al., 2015).
In Australia, approximately 90% of newly-acquired HCV infections
are due to the sharing of contaminated injecting equipment (The
Kirby Institute, 2015). Australia’s primary public health response
to HCV is focused on the distribution of sterile equipment (along
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with safer injecting advice) via government-funded needle syringe
programmes (Treloar and Fraser, 2007).
Integral to the prevention response has been the long-held
understanding that avoiding transmission is a matter of indi-
vidual responsibility (Dwyer et al., 2011; Fraser, 2004; Fraser
et al., 2014). This is reﬂected and reinforced not only through
the prevention education and health promotion materials pro-
duced for people who  inject drugs (PWID) (Dwyer et al., 2011;
Fraser, 2013), but the practical measures designed to enable the
fulﬁlment of this responsibility, such as the ways in which ster-
ile injecting equipment is distributed (Fraser et al., 2014). Despite
epidemiological and surveillance data consistently showing that
the majority of equipment sharing occurs between sexual part-
ners, this onus on individual responsibility has effectively elided
the importance of the intimate partnership as a key site of hep-
atitis C prevention and transmission (El-Bassel et al., 2014a,b;
http://dx.doi.org/10.1016/j.drugalcdep.2016.12.020
0376-8716/© 2017 Elsevier B.V. All rights reserved.
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Fraser, 2013; Rhodes and Quirk, 1998; Seear et al., 2012; Simmons
and Singer, 2006). Recent survey data, for example, indicate
that over 50% of participants who reported sharing injecting
equipment did so with their regular sexual partner (Iversen
and Maher, 2015), with similar patterns found in earlier stud-
ies (Roux et al., 2014; Bryant et al., 2010; Cao and Treloar,
2006).
This “individualising tendency” (Fraser et al., 2015) has impor-
tant implications for efforts to understand and prevent the
transmission of hepatitis C, particularly within couples where
arguably the risk is greatest. In this article we address this tendency
by adopting a methodology that positions partnerships rather than
individuals as the primary unit of analysis (Eisikovits and Koren,
2010; Simmons and Singer, 2006). Drawing on qualitative inter-
views with couples who inject drugs, we focus on those couples
that reported changes in HCV-status (or “sero-change”). We explore
how these participants responded to sero-changes within the lived
contexts of their intimate partnerships and how such changes
affected their perceptions of transmission risk.
Framing participants’ partnerships as the primary unit of anal-
ysis represents a novel and instructive way of thinking about HCV
transmission and prevention. Rarely have the intimate partner-
ships of PWID been conceptualised as units of analysis in their
own right, tending to be either overlooked or discounted as dys-
functional and drug-driven (Fraser, 2013; Keane, 2004; Seear et al.,
2012; Simmons and Singer, 2006). Recently there has been an
emergence of HIV-related research focussing on the “micro-social
contexts” of heterosexual couples who inject drugs (El-Bassel
et al., 2014a,b; Montgomery et al., 2012). This work emphasises
the need to move beyond individual-level, cognitive-based mod-
els of health behaviour, underscoring instead the importance of
a conceptual, motivational and “ideological shift from focusing
on the individual to the dyad” (Jiwatram-Negron and El-Bassel,
2014, p. 1885) − from an orientation of “self-care” and “inde-
pendence” to one prioritising “relationship”, “interdependence”
and “communal coping” (Montgomery et al., 2012). In this article
we build on these broad conceptual concerns via new empirical
territory: an exploration of the particularities of acquiring and
living with HCV among couples who inject drugs. Here a quali-
tative approach is not only well suited to capturing the richness
and subtleties of contextualised, interpersonal dynamics, it is also
particularly effective when exploring new and under-developed
areas of research such as people’s accounts of sero-change (Patton,
2002).
2. Materials and methods
2.1. Recruitment and data collection
This project used purposive sampling to recruit heterosexual
couples in which both partners identiﬁed as PWID. Recruitment
took place across four harm-reduction, inner-city services within
two Australian states, New South Wales and Victoria. Couples were
included on the basis that both partners agreed to be interviewed.
Each partner was interviewed separately by the same researcher,
with assurances of conﬁdentiality emphasised. Interviewing part-
ners separately, it was felt, would best facilitate the emergence
of sensitive intra-relationship talk (Eisikovits and Koren, 2010):
the attribution of responsibility (or “blame”) for HCV transmission
within couples, for example. Semi-structured interview schedules
were organised around the core themes of injecting drug use, HCV,
and intimate partnership. Interviews took between 30 and 60 min.
Each participant was reimbursed $30 to cover time and travel
expenses.
2.2. Data management
The total dataset comprised 80 qualitative, in-depth
interviews.1 All interviews were digitally recorded, tran-
scribed verbatim, de-identiﬁed and anonymised with the use
of pseudonyms. A coding frame was developed collaboratively by
the authors, drawing on the data itself, the interview schedule,
and our knowledge of the literature. Consistent with positioning
“the partnership” as the basic unit of analysis, transcripts were
entered as couples within a qualitative data management program,
NVivo 9. Consequently, any narrative detail extracted for analysis
was readily identiﬁable as part of a broader story of partnership
rather than simply an individual account. Individual theme ﬁles or
‘nodes’ were reviewed by all authors to assist with identifying and
consolidating key themes and concepts. The data analysed in this
article comprised 28 of the total 80 interviews, collected from the
14 couples that reported changes in HCV status during the course
of their relationship. Our focus was  on the node that collated all
data concerned with couples’ accounts of sero-change.
2.3. Analysis
Our analysis was conducted using a mix  of inductive (data-
driven) and deductive (analyst-driven) approaches (Braun and
Clarke, 2006). Induction enabled key themes to be identiﬁed in
the relevant node and subsequently corroborated against the orig-
inal transcripts. These emergent themes plus indicative quotes
were discussed among all authors. During this stage, summary
accounts of each couples’ sero-change story were also mapped
out (see Table 1). Accounts from some participants included rec-
ollections of confusion or “misinformation” regarding their status;
others described being uncertain, even perplexed, regarding the
circumstances of transmission. Within couples, too, partners some-
times made contradictory statements about the other’s status. A
deductive analytical approach enabled us to begin to make sense
of this apparent confusion or “mess”. The extant literature, includ-
ing our own earlier analyses of the dataset (see for example, Rance
et al., 2016; Treloar et al., 2015), provided an analytical frame-
work through which to interpret couples’ often complex accounts
of sero-change. Our ﬁnal analysis, including the three themes under
which our results are organised, reﬂect these elements of grounded
analysis (Glaser and Strauss, 1967) coupled with analyst-driven
deduction. Throughout the writing process, each subsequent iter-
ation incorporated suggestions from all authors, with differences
negotiated until agreement was reached.
The study was  approved by the Human Research Ethics Com-
mittee of The University of New South Wales (reference HC12430).
Written, informed consent was obtained from all participants. All
extracts cited here are identiﬁed by the participant’s pseudonym,
age and self-reported HCV status2 (at time of interview), followed
by their partner’s corresponding details, and the duration of their
relationship.
1 The 80 respondents comprised 34 couples, plus 12 “sole” participants included
on the basis of having had relationship experience (prior or current) involving inject-
ing  drug use.
2 Our use of terms in this paper refers to HCV-status as it relates to the poten-
tial for transmission. “HCV-positive” refers to chronic infection (antibody-positive
and RNA-positive); such a person is infectious to others. “HCV-negative” refers to
people without chronic infection (that is, antibody-negative and RNA-negative, or
antibody-positive and RNA-negative); such a person is not infectious to others.
“Exposure” refers to an exposure to HCV which did not result in chronic infection
(antibody-positive and RNA- negative). “Seroconversion” refers to exposure to HCV
which did result in HCV chronic infection (antibody-positive and RNA-positive).
We  use the term “sero-change” as a catchall to describe any change in HCV-status
reported by participants.
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Table 1
Participant accounts of sero-change.
aSeth34pos/Suzie46pos (2 yrs.)
1  seroconversion
Initially positive seroconcordant (i.e. at relationship outset). Seth reported subsequently
contracting an additional genotype (1a) via Suzie.
Janine48neg/Jim61pos (15 yrs.)
1 seroconversion + post-pregnancy
clearance
Initially serodiscordant. Janine reported subsequent seroconversion following accidentally sharing
a  needle-syringe with Jim. She reported clearing the virus following the birth of their child three
years later.
Fran29pos/Fred29pos (8 yrs.)
1  seroconversion or “clinical
mistake”
1 seroconversion
Initially negative seroconcordant. Fred reported a previous HCV-positive diagnosis but a
“negative” result at the start of the relationship. Believed his HCV had subsequently either “come
back” or that the clinician had been mistaken regarding his earlier “negative” result. Fran reported
contracting HCV after the relationship commenced, via Fred.
Debbie33pos/Dan33pos (14 yrs.)
1  seroconversion
Initially serodiscordant. Debbie reported subsequently contracting HCV via Dan and remaining
HCV-positive. Dan agreed he “gave it” to Debbie but believed she had subsequently cleared her
infection.
Keith40pos/Karen32neg (8 yrs.)
2 exposures + spontaneous
clearance
1 seroconversion
Initially positive seroconcordant. Both claimed to have been HCV-positive twice. Karen: “I had hep
C  and then it went away and come back and now it’s gone”; Keith: “I’ve got rid of it and got it again
.  . . I feel stupid”. Although unclear, it seems Keith’s latest infection was acquired during his
relationship with Karen but not via her. Karen reported she had been exposed to the virus twice
during the relationship (at least once via Keith) but is now HCV-negative. Keith, however, believes
they are both still HCV-positive. Accounts suggest Karen began injecting drug use after the
relationship began.
Terry37neg/Tegan38pos (6 yrs.)
1 seroconversion
Initially negative seroconcordant. Tegan reported subsequently contracting HCV via Terry except
he  reports always being HCV-negative.
Jenn31pos/Jimmy32pos (6 yrs.)
1 seroconversion or “clinical
mistake”
1 seroconversion
Initially negative seroconcordant. Both reported being diagnosed HCV-positive after beginning
relationship: Jenn for the ﬁrst time; Jimmy  for the second. Jimmy reported receiving a “positive”
diagnosis years earlier before later being told by a clinician that he had cleared the infection.
Suggested he then “got it again” after he started injecting with Jenn. Jenn, however, believed
Jimmy’s doctor had made a mistake and that Jimmy had not cleared his initial infection. Jenn
reported contracting HCV since meeting Jimmy  but was  unclear about source of transmission.
Ava33neg/Alan48pos (1 yr.)
1  exposure + spontaneous
clearance
Initially serodiscordant. Ava reported acute HCV symptoms after relationship began but
subsequently cleared infection. She recalled sharing spoons/ﬁlters with Alan but suspected
transmission had been via “this couple I used to share it with . . . a lot of times”. Alan reported he
had been HCV-positive for 20 years; believed Ava was still HCV-positive.
Les55pos/Libby26neg (1 yr.)
1  seroconversion
Initially negative seroconcordant. Les reported commencing injecting drug use two years
previously; shocked by HCV-positive diagnosis.
Charlie34neg/Crissy30neg (10 yrs.)
1 exposure + spontaneous
clearance
Initially negative seroconcordant. Crissy reported subsequently contracting HCV before
spontaneously clearing; perplexed by circumstances of exposure.
Tanya23pos/Tim39neg (9 yrs.)
1 seroconversion
2 exposures + spontaneous
clearance
Initially negative seroconcordant. Tanya reported subsequently contracting HCV while pregnant
via a non-drug related blood exposure. Tim reported two HCV exposures and spontaneous
clearance; vague about timeframes and details for both but did not link either directly to Tanya.
Shelly34pos/Steve33neg (8 yrs.)
2 seroconversions
1 clearance following treatment
Initially negative seroconcordant. Shelley introduced Steve to injecting drug use. Both reported
HCV-negative results following tests at start of the relationship. Shelley refused to show Steve her
results but insisted it was “negative”. Both reported subsequently seroconverting; speculation
from  about transmission source included: contaminated “street deal” and ex-partners. Steve later
successfully completed treatment.
Mindy39pos/Mac35neg (10mths)
1  clearance following treatment
Initially positive seroconcordant. Mac  reported successfully completing treatment during the
relationship.
Cameron39neg/Camila39neg (9
yrs.)
1 spontaneous clearance
Initially serodiscordant. Camila diagnosed HCV-positive prior to relationship. Although later tests
indicated Camila had cleared it, both she and Cameron believed her to be “positive” (i.e. infectious)
at  the start of the relationship.
a Couples identiﬁed by participant pseudonym; age; HCV status (by self-report at time of interview); and length of relationship.
3. Results
The 28 participants ranged in age from 23 to 61 years; their
relationships varied in duration from 10 months to 15 years.
Twelve participants identiﬁed as ‘Anglo-Australian’ or ‘Anglo-
New Zealander’, nine as Aboriginal and Torres Strait Islander,
and the remainder as Australian-Armenian (n = 2), Greek-Italian
(n = 2), Hungarian (n = 1), Scandanavian (n = 1) and Indian (n = 1).
Three quarters of participants (n = 21) received some form of
social welfare, ﬁve worked full-time (n = 3) or part-time (n = 2),
one was dependent on his partner’s income and one declined to
answer. Based on self-reported status at the time of interview,
two couples identiﬁed themselves as HCV-negative, four couples
as HCV-positive, and the remaining eight as serodiscordant. The
couples reported a total of thirteen seroconversions (including
two instances alternatively described as “clinical mistakes”), eight
exposures-plus-spontaneous-clearances and two successful treat-
ment outcomes.
This section explores participants’ accounts of sero-change via
three themes identiﬁed in the data: negotiating new diagnoses and
accommodating chronic infections; status confusion; and the pri-
oritisation of partnership.
3.1. Sero-change: new diagnoses and chronic infections
While participants’ accounts of negotiating a new diagnosis
within the context of intimate partnership varied markedly accord-
ing to the relational, social and viral speciﬁcities of their situation –
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including stated beliefs regarding the source of transmission – they
invariably shared an overarching concern for the effect it might
have on their relationship.
“It’s almost like having to tell your partner you’re pregnant or
something, it’s really fucking scary . . . it tests your relationship,
it really does.”
(Crissy30neg following spontaneous clearance, Charlie34neg,
10 years)
“I hate it, I was so ashamed, and I didn’t tell [partner Dan] that I
had caught it off him for, say, like 13 months . . ..”
(Debbie33pos, Dan33pos, 14 years)
“I didn’t contract genotype 3 until a lot later in life. I was  only
diagnosed with that in the last 18 months . . . It’s most probable
that I got it from [Suzie] . . . I’m very happy and lucky in the sense
that I’m glad that she hasn’t got my  genotype 1, which seems to
be a bit more problematic at times for people.”
(Seth34pos, Suzie46pos, 2 years)
Crissy recalled feeling bewildered by her diagnosis, stating she
had “never shared or used someone else’s needles.” Nonethess,
these feelings were ultimately secondary to her fear of transmit-
ting the virus to her partner in the period before her spontaneous
clearance was identitied: “the guilt would just kill me.” For Debbie,
her reluctance to tell her partner Dan was bound up with feelings
of shame but also her desire to protect him from similarly uncom-
fortable emotions: “I didn’t want him to blame himself and feel
bad, because it wasn’t his fault that he got it either.” However, for
Seth (already living with genotype 1), “It was kinda just like accep-
tance. I was more concerned when the results were coming back
that ‘please don’t let [Suzie] get what I’ve got.”’
Participants reported a range of emotional, discursive, and
practical concerns and accommodations to living with long-term
sero-change within their partnerships. Beyond a shared expression
of concern among parenting participants about preventing house-
hold transmission to children, these accounts were diverse. For
Fran, who reported seroconverting via her partner Fred and initially
feeling “devastated”, living with HCV “actually hasn’t been like a big
thing.” Fred reported that his one concern was  “that I don’t want
her to feel angry if she feels I gave it to her.” Partners Debbie and
Dan adopted a strategy of relative “sero-silence” (Persson, 2008)
in what appeared to be a mutual (if unspoken) effort to normalise
their relationship in the face of internalised stigma and shame. For
Jenn and Jimmy, who both reported seronverting whilst together
but expressed uncertaintly about the source of transmission, their
confusion emerged from time to time in moments of tension within
their relationship.
“It’s a hard thing to talk about . . . you try and keep it as low as
possible. We’ve had a few talks about it, but not as much as we
should.”
(Dan33pos, Debbie33pos, 14 years)
“A little bit of ‘who gave it to who?’ . . . The occasional ‘well
you gave me  hep C!’ And it can be used against you, and when
you don’t know where it comes from that doesn’t help either,
because you don’t want either party to have it.”
(Jimmy32pos, Jenn31pos, 6 years)
3.2. Status confusion
Also commonplace (and evidenced in participants’ excerpts
above) was uncertainty and confusion regarding HCV-status and/or
the circumstances of transmission. Both Camila and Crissy, for
example, were perplexed by their diagnoses. For Crissy and her
partner Charlie, the distress caused by both the diagnosis itself,
and the uncertainty of the circumstances surrounding transmis-
sion, seemed to be unnecessarily compounded by a delay Crissy
experienced in receiving a follow-up PCR3 test.
“They said it was  a blood-borne thing, but I was  so careful . . .
like I never used anybody’s [injecting equipment], so how did
their blood connect to my  blood?”
(Camila39neg following spontaneous clearance,
Cameron39neg, 9 years)
“It’s something that I’ve really thought about because, like I said,
I’ve never shared a needle . . . Charlie hasn’t got it and I haven’t
used his needles. So, it was a real mystery to me . . . Something
I really, really ponder and pondered with Charlie as well . . . My
doctor was more of a sports doctor . . . I hassled him and hassled
him and hassled him for a year and a half to do the PCR test.
Turned out I cleared it myself, so for a year and a half . . . That
was  a really horrible part of my  life.”
(Crissy30neg following spontaneous clearance, Charlie34neg,
10 years)
A number of participants reported that clinical “mistakes” or
“misunderstandings” were the source of their confusion about
status. For others, understanding the circumstances of transmis-
sion, or simply their current status, was complicated by a complex
chronology of events: of previous relationships ending and new
ones beginning, HCV testing window periods and so on.
“At the start [of our relationship] I went and got blood tests, and
the doctor did a mistake: he told me  I was  clean and then I went
back a couple of months later and said, ‘are you sure?’ And when
he checked I had hep C . . .”
(Fred29pos, Fran29pos, 8 years)
“When I met  him [partner Jimmy], he thought he didn’t have it
. . . The doctor actually made a mistake . . . I think he did actually
have it [and] the doctor got it mixed up.”
(Jenn31pos, Jimmy32pos, 6 years)
“I don’t know if [HCV] was from my  old partner . . . I had a test
done [at the beginning of current relationship] and it was  clear,
but then sometimes they say it can take up to 6 months to show
up in the test.”
(Shelly34pos, Steve33neg following treatment, 8 years)
In addition to HCV-related confusion and uncertainty among
participants, there were several sets of partners whose respective
accounts of status appeared to be in clear contradiction. Debbie
believed she was still living with a chronic infection, while her part-
ner Dan expressed the conviction that she had cleared it. Karen and
Keith both reported seroconverting twice, yet Karen also reported
clearing her infections on both occasions; Keith, however, believed
that she, like himself, was  still HCV-positive. Tegan and Terry’s
accounts provided another permutation: while Tegan was  adamant
she had contracted HCV via Terry, Terry himself reported never hav-
ing been HCV-positive. While Tegan agreed that Terry was  no longer
HCV-positive, she argued that he had either “secretly” undergone
treatment in prison or had spontaneously cleared it.
3.3. Prioritising partnership
Accompanying participants’ diverse, sometimes contraditory,
accounts of negotiating HCV within their relationships was an
important series of statements in which the centrality of the part-
nership, and its priority over HCV-related concerns, was  articulated.
3 A PCR test can detect infectious agents directly, as opposed to antibodies which
are produced in response to infection (Dore, 2009). Approximately 25% of people
exposed to HCV do not go on to develop chronic infections but will nonetheless
remain “antibody-positive”. A PCR test should therefore be included as part of a
complete virological assessment in order to avoid confusion.
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Libby’s response to her partner’s diagnosis (from an unknown
source) captures the essence of this commitment: “Well, I just said
to him, ‘don’t think I’m going to leave you over it or anything like
that’, because I didn’t want him to worry” (Libby26neg.; Les55pos.,1
year). Similarly, Debbie reported insisting to her partner that,
despite his responsibility for her contracting HCV, “I’m always going
to be with you, so don’t worry!” For Janine, the “good responsibility”
her partner Jim had consistently demonstrated around the manage-
ment of his HCV helped consolidate their relationship, making her
feel cared for and “valued” (Janine48neg. following spontaneous
clearance; Jim61pos., 15 years). Her suggestion that HCV-positive
partners can demonstrate their love and support by making sure
that they “deal with it” was reiterated by a number of partici-
pants. As Libby (cited above) went on to explain: while she did
not want Les to worry, “I wanted him to learn about [HCV].” This
complex interplay of intimacy, partnership and status is insight-
fully captured by Janine in an observation about sero-discordant
relationships: “Sometimes you [the ‘negative partner’] can show
your love by showing them that it’s not important, but they [the
“positive partner”] show their love by saying that it is important.”
In addition to these observations, a number of participants
framed their experiences of sero-change within broader narra-
tives of personal and relational transformation: HCV came to mean
something different to them over time. For Jimmy, attending to his
and his partner’s HCV had become a priority:
“Once we’ve lost [HCV], I would not do it again to a person and
I would not like to get it back. Because it was clumsiness from
the addiction – you don’t care about it – but now we’re down
this stage of the track, it is the ﬁrst thing on the mind.”
(Jimmy32pos, Jenn31pos, 6 years)
While for Suzie, her relationship with Seth catalysed a change
in her knowledge and attitude towards HCV:
“[Seth] actually educated me  on it . . . About the genotypes and
the interferon and everything. He’s very knowledgeable in that
area; more so than me  . . . Now I’ve got to do 6 months of inter-
feron to correct my  carelessness in the past.”
(Suzie46pos, Seth34pos, 2 years)
While some participants acquired or sought greater biomedical
understanding as a means of coming to terms with sero-change,
others employed explanatory frameworks that sat ﬁrmly outside
conventional biomedical discourse. Drawing on a number of alter-
native logics or “rationalities”, these participants were primarily
concerned with limiting the potential social and relational damage
associated with contracting HCV. The virus itself meant something
different when transmitted within the partnership rather than out-
side it. Jenn, for example, explained the difference between Jimmy’s
experience of contracting HCV via a friend’s “betrayal” and, years
later, their experience together when she seroconverted. Fred too,
accommodated (“rationalised”) Fran’s seroconversion within a nar-
rative of romantic intimacy.
“He’s just never gotten over it, of course not . . . Whereas what
happened with us [seroconversion] was an accident . . . It’s very
different from a friendship to a relationship . . . in a relationship,
you love each other, you don’t want to harm each other. That’s
the way I look at it.”
(Jenn31pos, Jimmy32pos, 6 years)
“Most likely I gave [HCV] to [Fran], because we share utensils
but . . . it’s only with one partner, it’s not like I share it with
everyone. And because we’re soul mates for life, it doesn’t really
matter . . .”
(Fred29pos, Fran29pos, 8 years)
Tim and Karen similarly articulated socially and relationally sit-
uated rationalities, constructing a hierarchy of equipment sharing
based on a logic of social rather than sero status. While Tim, like Jenn
and Fred, referenced Western tropes of romantic love in order to
differentiate between sharing equipment with a friend and a part-
ner, Karen drew on notions of kinship to extend the intimacy, and
thus the acceptability, of sharing to include family members.
“I usually let her [inject] ﬁrst, even though she’s the one who’s
got hep C . . . To me  she’s still my  lady and she goes ﬁrst no matter
what . . . We’ve both got each other’s best interests at heart. Now
my  mate, we  could be mates for years [but] the main thing in
his head though is not going to be ‘Oh fuck, I hope he doesn’t
get sick or anything’, you see where I’m going? So there’s that
emotional connection with [a partner] as well as just the fact
we’re friends or we use together.”
(Tim39neg, Tanya23pos, 9 years)
“I don’t really use [injecting equipment] after anyone. Only like
my partner or my  sister or my  real close cousin. Because they’re
family. Like with my sister, we  got the same blood.”
(Karen40pos, Keith32neg, 8 years)
4. Discussion
In this article we  have focussed on participants’ accounts
of changing HCV-status within the context of their intimate
partnerships. While some couples sought greater biomedical
understanding as a means of coming to terms with sero-change,
others drew on alternative rationalities that sat ﬁrmly outside con-
ventional biomedical discourse. Regardless of which explanatory
framework they drew on, participants ultimately prioritised the
security of their relationship over the dangers of viral infection. The
intimate partnerships of PWID may  function as forms of social care
and protection in relation to typically hostile social environments
and structural vulnerability (Seear et al., 2012). As Rhodes and
Cusick (2000) suggest, “efforts to protect intimacy and relationships
from risk may  be particularly important in lives perceived to be par-
ticularly insecure or continually under threat” (p.4). Among people
who are socially excluded, including many who  inject drugs, mean-
ingful intimate relationships may  provide one of the few forms of
social capital available to them (Stevenson and Neale, 2012). We
need to recognise then, that within such partnerships the nego-
tiation of risk is as much an enactment of emotional intimacy as
of reasoned action: that ensuring the ongoing maintenance of the
relationship is itself a form of risk management (Rhodes and Quirk,
1998). As our ﬁndings suggest, participants frequently prioritised
the security – the ‘emotional refuge’ (Syvertsen et al., 2013) – of
intimate partnership over competing concerns, including those of
viral safety.
Enacting effective prevention and care, we  argue, requires mov-
ing beyond the employment of narrowly-deﬁned, individual-level
psychological models of behaviour – beyond simple injunctions to
take “individual responsibility” (Fraser, 2004) – to acknowledge the
often complex interpersonal, social and structural imperatives gov-
erning intimate (and other) relationships among PWID. We  need
to better acknowledge and work with the competing priorities and
complex realities of such partnerships beyond simply the identi-
ﬁcation of viral risk. We  need to recognise that, as Hepworth and
Krug (1999) argue, “While medical and psychological knowledge
are necessary and relevant in the case of HCV, they are not the sole
basis, nor necessarily the primary basis, on which individuals act”
(p. 245).
We recognise that this study was designed in ways that could
affect the ﬁndings. We have drawn on couples that reported
changes in HCV-status whilst remaining together. Consequently
there was less likelihood of attracting accounts from couples for
whom the pressure of status change contributed to the end of their
relationship. More broadly, recruitment required self-selection and
J. Rance et al. / Drug and Alcohol Dependence 173 (2017) 78–84 83
participation from both partners. This too may  have shaped the
dataset and the kinds of partnerships studied; it could have, for
example, reduced the likelihood of making contact with couples
affected by inter-partner violence and abuse. While we  noted a
general absence of gendered inequity within our dataset (only
two female participants provided explicit accounts of diminished
power and agency within their relationship) we  cannot be sure that
such experiences were not more widespread.
Participants were adept at accommodating changes to status
within the lived contexts of their private lives and relationships.
For our participants, the meaning of risk and safety was  multi-
ple, socially and relationally situated, rather than singular, ﬁxed
and pre-determined. Even serodiscordance itself was perceived
in diverse and unexpected ways, encompassing a range of mean-
ings and practices among participants (Persson, 2013). This is
perhaps not surprising, given that, as others have argued (Fraser
and Seear, 2011; Hepworth and Krug, 1999), the meanings of
diagnosis and living HCV are “embedded” within the social and
cultural dimensions of everyday life and relationships. Participant
accounts of status confusion and contradiction, of doctor’s mis-
takes and lay (mis)understandings, need to be balanced against
the limitations of conventional biomedical approaches to HCV edu-
cation and care. Social researchers have consistently described
the disconnection reported between people’s lived experience
of HCV and biomedical concerns focussed solely on the physi-
cal body (Harris, 2005; Krug, 1995; Sutton and Treloar, 2007).
As Rhodes and Treloar (2008) argue, biomedical responses can
be “at extreme odds with the situated and competing prior-
ities of people who inject drugs” (p. 1330). Nonetheless, our
results do suggest the need to continually engage those who
inject drugs, in both HCV testing and in improving the systems
by which these tests and resultant information are provided.
With the “new era” of direct acting antiviral treatments promis-
ing to profoundly change what it means to acquire and live with
HCV, opportunities will arise to learn to integrate biomedical
information within more socially sophisticated, relationally aware
approaches.
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